ArticleBiosensors2026
Development of a Horseradish Peroxidase-Based Electrochemical Biosensor for Melatonin Detection.
Article in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A horseradish peroxidase (HRP)-based electrochemical biosensor was developed for melatonin (MLT) detection using a graphene-modified screen-printed electrode (G/SPE). HRP was immobilized at different temperatures (4 °C and 20 °C) and enzyme amounts (10 and 20 µL of 5 mg/mL HRP solution) to optimize the performance of the biosensors. FTIR analysis confirmed successful enzyme immobilization, while differential pulse voltammetry (DPV) showed a clear oxidation peak of MLT at 1.1 V with enhanced current responses for HRP-modified electrodes. The optimal biosensor, prepared at 4 °C with 10 µL enzyme of 5 mg/mL HRP solution, exhibited the best analytical performance, with a linear range of 0.4-3.6 µM, and a detection limit of 1.02 µM. Kinetic studies confirmed strong enzyme-substrate affinity, while the biosensors demonstrated excellent repeatability and a good stability. The method was successfully validated on pharmaceutical products, proving to be a reliable and an accurate tool for MLT quantification in real samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.